Common Prior Authorization Criteria BMI documentation: Most states require a documented BMI of 30 or greater, or 27 or greater with at least one weight-related comorbidity (hypertension, type 2 diabetes, dyslipidemia, obstructive sleep apnea) Failed lifestyle modification: Typically 3 to 6 months of documented dietary counseling and physical activity recommendations that did not produce adequate weight loss Step therapy: Some states require patients to try and fail less expensive medications (phentermine, orlistat) before approving GLP-1 coverage Provider qualification: Some Medicaid plans require the prescriber to have completed training in obesity medicine
However, what drew the attention of the beauty industry was its capacity to lighten the skin by inhibiting melanin formation
) , , , , , , , , , BPC-157 : Thymosin Beta-4 (TB-500) , GHRP/GHRH LL-37 /
The effect of omega-3 fatty acids on sarcopenia: mechanism of action and potential efficacy
Patients in the program receive ongoing provider monitoring, personalized dosing, and guidance to support long-term results
What Is GLP-1 and Why Should You Care
